Carl Bjartmar
Keine laufenden Positionen mehr
Profil
Carl Bjartmar worked as a Senior Medical Director at Sanofi Aventis AB and Genzyme AB.
He then served as the Chief Medical Officer at Wilson Therapeutics AB from 2015 to 2018 and at Ascelia Pharma AB from 2018 to 2022.
He holds a doctorate degree from the University of Linköping.
Ehemalige bekannte Positionen von Carl Bjartmar
| Unternehmen | Position | Ende |
|---|---|---|
| ASCELIA PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2022 |
| WILSON THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - |
Sanofi Aventis AB
 Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Carl Bjartmar
| University of Linköping | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sanofi Aventis AB
Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | |
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
